Zhejiang Hisun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000013Z2
  • SHG: 600267
CNY
11.87
0.49 (4.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Positive results in Jun 26

  • INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
  • NET PROFIT(HY) Higher at CNY 637.4 MM
  • ROCE(HY) Highest at 10.13%
2

With ROE of 8.20%, it has a fair valuation with a 1.31 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 15,697 Million (Large Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.62%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

8.20%

stock-summary
Price to Book

1.75

Revenue and Profits:
Net Sales:
2,085 Million
(Quarterly Results - Jun 2026)
Net Profit:
283 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.51%
0%
20.51%
6 Months
15.13%
0%
15.13%
1 Year
12.73%
0%
12.73%
2 Years
68.61%
0%
68.61%
3 Years
10.73%
0%
10.73%
4 Years
15.69%
0%
15.69%
5 Years
-8.62%
0%
-8.62%

Zhejiang Hisun Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-2.87%
EBIT Growth (5y)
-1.79%
EBIT to Interest (avg)
4.41
Debt to EBITDA (avg)
2.51
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.78
Tax Ratio
32.28%
Dividend Payout Ratio
45.11%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.83%
ROE (avg)
6.61%

Valuation key factors

Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.31
EV to EBIT
12.62
EV to EBITDA
7.19
EV to Capital Employed
1.30
EV to Sales
1.18
PEG Ratio
0.49
Dividend Yield
2.16%
ROCE (Latest)
10.26%
ROE (Latest)
8.20%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -12.78% vs -9.00% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -21.00% vs 351.51% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,085.00",
          "val2": "2,390.50",
          "chgp": "-12.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "583.70",
          "val2": "535.50",
          "chgp": "9.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.00",
          "val2": "16.70",
          "chgp": "-28.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-0.40",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "283.20",
          "val2": "358.50",
          "chgp": "-21.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "167.90%",
          "val2": "126.30%",
          "chgp": "4.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.95% vs -0.41% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.41% vs 709.59% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,488.60",
          "val2": "10,287.50",
          "chgp": "1.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,079.90",
          "val2": "1,837.20",
          "chgp": "13.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "104.90",
          "val2": "161.40",
          "chgp": "-35.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-223.60",
          "val2": "-141.30",
          "chgp": "-58.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "547.50",
          "val2": "591.30",
          "chgp": "-7.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "105.20%",
          "val2": "72.50%",
          "chgp": "3.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
2,085.00
2,390.50
-12.78%
Operating Profit (PBDIT) excl Other Income
583.70
535.50
9.00%
Interest
12.00
16.70
-28.14%
Exceptional Items
-0.80
-0.40
-100.00%
Consolidate Net Profit
283.20
358.50
-21.00%
Operating Profit Margin (Excl OI)
167.90%
126.30%
4.16%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -12.78% vs -9.00% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -21.00% vs 351.51% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
10,488.60
10,287.50
1.95%
Operating Profit (PBDIT) excl Other Income
2,079.90
1,837.20
13.21%
Interest
104.90
161.40
-35.01%
Exceptional Items
-223.60
-141.30
-58.24%
Consolidate Net Profit
547.50
591.30
-7.41%
Operating Profit Margin (Excl OI)
105.20%
72.50%
3.27%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 1.95% vs -0.41% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -7.41% vs 709.59% in Dec 2024

stock-summaryCompany CV
About Zhejiang Hisun Pharmaceutical Co., Ltd. stock-summary
stock-summary
Zhejiang Hisun Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available